MoneyWorks4Me

Marksans Pharma - Quaterly Results

27 May 2026 Evaluate
A fair growth of 20.78% in the revenue at Rs. 3615.73 millions was reported in the March 2026 quarter as compared to Rs. 2993.57 millions during year-ago period.Net Profit witnessed a 144.53% growth almost the double from Rs. 375.91 millions to Rs. 919.23  millions  of same quarter last year.Operating profit for the quarter ended March 2026 rose to 1334.67 millions as compared to 583.91 millions of corresponding quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 3615.73 2993.57 20.78 13414.76 11743.74 14.23 13414.76 11743.74 14.23
Other Income 274.75 66.36 314.03 1035.33 657.87 57.38 1035.33 657.87 57.38
PBIDT 1334.67 583.91 128.57 4271.00 2738.85 55.94 4271.00 2738.85 55.94
Interest 3.53 3.11 13.50 13.27 11.74 13.03 13.27 11.74 13.03
PBDT 1331.14 580.80 129.19 4257.73 2727.11 56.13 4257.73 2727.11 56.13
Depreciation 87.56 81.77 7.08 342.30 294.52 16.22 342.30 294.52 16.22
PBT 1243.58 499.03 149.20 3915.43 2432.59 60.96 3915.43 2432.59 60.96
TAX 324.35 123.12 163.44 908.45 549.87 65.21 908.45 549.87 65.21
Deferred Tax 23.27 7.54 208.62 45.54 28.43 60.18 45.54 28.43 60.18
PAT 919.23 375.91 144.53 3006.98 1882.72 59.71 3006.98 1882.72 59.71
Equity 453.16 453.16 0.00 453.16 453.16 0.00 453.16 453.16 0.00
PBIDTM(%) 36.91 19.51 89.24 31.84 23.32 36.52 31.84 23.32 36.52
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..